If you’ve read the sprawling behemoth that is my critique of (now not so) recent stroke literature you’ll notice that it ends with a spiel on IST-3 – the big 3000 pt RCT that hopes to settle the question of … Read More »
Only a quickie this time. I mentioned in the first part that I wasn’t planning to discuss the details of the MAST trials as they used streptokinase as the agent and this is no longer used. In short both trials … Read More »
This is part 2 of a series of posts considering the evidence for thrombolytics in stroke. Part one can be found here SITS-ISTR and SITS-MOST You may have seen these two trials. The most important thing to be said about … Read More »
I’ve presented on this a couple of times but this is gonna require a few parts, so be patient with me. This is not quite a deep-dive in the SMART EM sense, more of a shallow dive you might do … Read More »